Mersana Therapeutics Inc.

NASDAQ: MRSN · Real-Time Price · USD
7.14
-0.28 (-3.77%)
At close: Aug 15, 2025, 3:59 PM
7.44
4.20%
After-hours: Aug 15, 2025, 06:16 PM EDT

Mersana Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-24.3M -24.12M -14.12M -11.5M -24.27M -19.31M -19.54M -41.66M -54.31M -56.16M -44.92M -59.81M -52.22M -47.26M -48.98M -45.47M -40.91M -34.69M
Depreciation & Amortization
287K 316K 400K -2.93M 403K 423K 447K 427K 324K 319K 282K 213K 227K 205K 211K 212K 206K 226K
Stock-Based Compensation
1.99M 2.77M 3.35M 4.03M 4.42M 4.66M 4.08M 4M 6.64M 6.41M 5.31M 5.38M 5.35M 5.49M 4.86M 4.93M 4.58M 4.04M
Other Working Capital
n/a -9.11M -12.48M 1.63M -1.97M -13.97M -16.32M -4.03M -11.49M -13.04M 19.18M 94.43M -4.28M 35.94M -2M 8.89M 2.76M -47K
Other Non-Cash Items
-582K 775K 307K 610K -435K 9.37M -227K 217K 167K -1.26M -877K 193K 187K 194K 604K 42K 39K 38K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a 2.83M -1.05M -1.78M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
n/a -9.07M -9.19M 1.22M -1.98M -18.13M -21.74M -8.02M -12.88M 21.69M -11.02M 108.92M 1.78M 33.42M 908K 4.19M 1.62M 3.37M
Operating Cash Flow
-22.6M -29.33M -19.25M -8.58M -21.86M -32.66M -34.15M -46.08M -61.83M -29M -51.23M 54.6M -44.78M -7.96M -42.4M -36.1M -34.47M -27.02M
Capital Expenditures
n/a n/a n/a n/a n/a -132K -386K -472K -399K -911K -785K -426K -657K -329K -155K -46K -333K -114K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a 101.52M -104.25M 5.04M -2.31M 54M n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a -26.53M -19.49M -87.42M -24.47M -9.72M -58.04M -63.69M -87.64M -70.06M -89.81M n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a 27M 50M 55M 25M 15M 45M 113.97M 53M 66M 43M n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
395K n/a n/a n/a n/a -72.42M -101.52M 104.25M -5.04M 2.31M -54M -16.07M -89.81M n/a n/a n/a n/a n/a
Investing Cash Flow
395K 27M 50M 28.47M 5.51M -72.55M 20.15M 103.78M -5.44M 1.4M -45.43M -16.49M -90.47M -329K -155K -46K -333K -114K
Debt Repayment
n/a -3.14M -2.1M -23K -47K -65K -66K -65K -66K 21.52M -65K -65K -66K -76K 18.48M -65K -41K -33K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a 1.2M -81K n/a n/a n/a n/a n/a n/a n/a n/a n/a -259K
Dividend Paid
n/a n/a n/a n/a n/a n/a -227K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-3.11M n/a n/a n/a 266K 48K 158K n/a 1.36M -21.7M 1.58M 110K 606K 96K 515K 528K 619K 505K
Financial Cash Flow
-3.11M -3.14M -1.87M -23K 153K 5.83M 92K -146K 73.18M 21.55M 41.46M 10.64M 40.53M 60.39M 28.8M 463K 33.92M 472K
Net Cash Flow
-25.32M -5.46M 28.88M 19.87M -16.19M -99.38M -11.72M 57.55M 5.91M -6.06M -55.2M 48.74M -94.72M 52.11M -13.76M -35.68M -885K -26.66M
Free Cash Flow
-22.6M -29.33M -19.25M -8.58M -21.86M -32.79M -34.53M -46.55M -62.23M -29.92M -52.01M 54.17M -45.43M -8.28M -42.55M -36.14M -34.8M -27.14M